PROSTATE Journal

publication venue for

Inverse agonism at the Na/K-ATPase receptor reverses EMT in prostate cancer cells 2021
Ser-486/491 phosphorylation and inhibition of AMPK activity is positively associated with Gleason score, metastasis, and castration-resistance in prostate cancer: A retrospective clinical study. 78:714-723. 2018
Lin28 induces resistance to anti‐androgens via promotion of AR splice variant generation. 76:445-455. 2016
Raf Kinase Inhibitor Protein (RKIP) Deficiency Decreases Latency of Tumorigenesis and Increases Metastasis in a Murine Genetic Model of Prostate Cancer. 75:292-302. 2015
Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). 74:1086-1094. 2014
Functional p53 determines docetaxel sensitivity in prostate cancer cells. 73:418-427. 2013
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. 73:328-335. 2013
RhoGDIα downregulates androgen receptor signaling in prostate cancer cells. 73:1614-1622. 2013
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. 72:82-89. 2012
RhoGDIα suppresses growth and survival of prostate cancer cells. 72:392-398. 2012
Microarray analysis reveals potential target genes of NF-κB2/p52 in LNCaP prostate cancer cells. 70:276-287. 2010
Interleukin-4 activates androgen receptor through CBP/p300. 69:126-132. 2009
NF-κB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. 68:1725-1733. 2008
Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. 67:1293-1300. 2007
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. 67:764-773. 2007
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). 66:1070-1075. 2006
Requirement for NF-κB in interleukin-4-induced androgen receptor activation in prostate cancer cells. 64:160-167. 2005

category

ENDOCRINOLOGY & METABOLISM Category
UROLOGY & NEPHROLOGY Category

International Standard Serial Number (ISSN)

0270-4137

Electronic International Standard Serial Number (EISSN)

1097-0045

journal abbreviation

PROSTATE